|
[5] S. Rogelj, D.F. Stern and M.
Klagsbrun: Construction and Expression
of a Transforming Gene Resulting From a Fusion of a Basic FGF Gene with
a Signal Peptide Sequence. In: Peptide Growth Factors, Methods in
Enzymology,
198, 117-124. D. Barnes, J.P. Mather and G.H. Sato, eds. Academic Press,
1991.
[4] M. Klagsbrun, P. Fanning and S. Rogelj: Ras Transformation in 3T3
cells induces fibroblast growth factor synthesis in vitro and in vivo.
In: Molecular Mechanisms in Cellular Growth and Differentiation. Biomedical
Sciences Symposia, 1989.
[3] S. Rogelj and M. Klagsbrun: Oncogenic Transformation by Basic Fibroblast
Growth Factors. In: Paracrine and Autocrine Factors in Reproductive Endocrinology,
p.19-28. Bela J. Gulyas and Lewis C. Krey, eds. Plenum Press, 1989.
[2] S. Rogelj and M. Klagsbrun: Basic Fibroblast Growth Factor Induces
Tumorigenicity in Immunocompetent Animals Only After Acquiring a Signal
Peptide. Progress in Endocrinology, 517-522. Imura et al., editors. Elsevier
Science Publishers B.V., Biomedical Division, 1988.
[1] S. Rogelj, M.Klagsbrun and R.A. Weinberg: The Basic Fibroblast Growth
Factor (bFGF) Gene Can Function as an Oncogene. Symposium on: Molecular
Biology in Hematology, Trapani, Italy, 6 Sept 1987 p.67-80. (National
Research Council; Italian Society for Hematology.)
|
|
[17]
Rogelj S. Reiter K.J., Kesner L., Li M. and Essex D.: Enzyme Destruction
by a Protease Contaminant in Bacitracin. Manuscript accepted for publication
in Biochemical and Biophysical Research Communications. 6/5/2000
[16]
Bennett T.A., Edwards,B.S., Sklar L.A. and Rogelj S.: Sulfhydryl Regulation
of L-Selectin: Promotion of Activation Independent L-selectin Shedding
from Leukocytes. Journal of Immunology 164:4120-4129 (2000)
[15] Guyer D. A.,
Moore K., Schammel C.M.G., Lynam E., Bennett T., Rogelj S,
Edwards B.S., Mellors A., McEver R., and Sklar, L.A.: P-Selectin
Glycoprotein Ligand-1(PSGL-1) is a Ligand for L-selectin in
Neutrophil Aggregation. Blood; 88:(7) 2415-2421 (1996).
[14] Lynam E.B.,
Rogelj S., Edwards, B.S. and Sklar, L.A.: Enhanced aggregation in human
neutrophils by MnCl2 or DTT differentiates the roles of L-selectin and
beta2-integrins. Journal of Leukocyte Biology; 60: 356-364, (1996).
[13] Bennett T.A., E.B. Lynam, Sklar L.A. and Rogelj S.:
Hydroxamate-based metalloprotease
inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes:
functional consequences for neutrophil aggregation. Journal of Immunology;
156: 3093-3097 (1996).
[12] Bennett T.A.,
Schammel C.M.G., Lynam E.B., Guyer D.A., Mellors A., Edwards B., Rogelj
S. and Sklar L.A.: Evidence for a third component in neutrophil aggregation:
potential roles of O-linked glycoproteins as L-selectin counter-structures
Journal of Leucocyte Biology, 58: 510-518 (1995).
[11] Goldstein
B., Rogelj S., Siegal S., Farmer S.R., Niles R.M.: Cyclic AMP mediated
induction of F9 teratocarcinoma differentiation in the absence of retinoic
acid. Journal of Cellular Physiology, 143(2):205-212 (1990).
[10] W.E.Serafin, D.S.Reynolds, S.Rogelj, W.S.Lane, G.Conder,
S.S.Johnson, K.F.Austen and R.L.Stevens: Identification and Molecular Cloning of a Novel Mouse Mucosal
Mast Cell Serine Protease. Journal of Biological Chemistry, 265(1): 423-429
(1990)
[9] S.E. Egan,
L. Jarolim, S. Rogelj, M. Spearman, J.A. Wright and A.H. Greenberg: Growth
Factor Modulation of Metastatic Lung Colonization. Anticancer Research,
10: 1341-1346 (1990).
[8] N. Iberg,
S. Rogelj, P. Fanning and M. Klagsbrun: Purification of 18 kDa and 22
kDa forms of basic fibroblast growth factor in cells transformed by the
ras oncogene. Journal of Biological Chemistry, 264 (33): 19951-19955 (1989).
[7] S. Rogelj,
M. Klagsbrun, R. Atzmon, M. Kurokawa, A.Haimovitz, Z. Fuks and I.
Vlodavsky:
Basic fibroblast growth factor is an extracellular matrix component required
for supporting the proliferation of vascular endothelial cells and the
differentiation of PC-12 cells. Journal of Cell Biology, 109: 823-831
(1989).
[6] S. Rogelj, R.A. Weinberg, P. Fanning and M.
Klagsbrun: Characterization of Tumors
Produced by Signal Peptide-bFGF Transformed Cells. Journal of Cellular
Biochemistry, 39: 13-24 (1989).
[5] R. Hannan,
S. Kourembans, K. Flanders, S. Rogelj, A. Roberts, D. Faller and M.
Klagsbrun:
Human Endothelial Cells Synthesize Fibroblast Growth Factor and Transforming
Growth Factor Beta. Growth Factors, 1:7-17 (1988).
[4] S. Rogelj, R.A. Weinberg, P. Fanning and M.
Klagsbrun: Basic Fibroblast Growth Factor (bFGF) Fused to a Signal Peptide Transforms Cells. Nature, 331(6152):
173-175 (1988).
[3] S.H. Friend,
R. Bernards, S. Rogelj, R.A. Weinberg, J.M. Rappaport, D.M. Albert and
T.P. Dryja: Identification of a Human DNA Segment Having Properties of
the Gene that Predisposes to Retinoblastoma and Osteosarcoma. Nature,
323 (6089): 643-646 (1986).
[2] R.M. Niles,
B. Loewy and S. Rogelj: The Effect of Retinoic acid on Protein Phosphorylation
in Mouse Melanoma Cells. Experimental Cell Research, 164: 437-44 (1986).
[1] S. Rogelj,
B. Loewy and R.M. Niles: The Effect of Retinoic Acid on Cyclic AMP Binding
Proteins in Mouse Melanoma Cells. European Journal of Biochemistry, 139:
351-357 (1984).
|